Published • loading... • Updated
Frost & Sullivan Released the 2026 Global Gene Therapy Industry Development Blue Book
- Frost & Sullivan released its 2026 Global Gene Therapy Industry Development Blue Book in October 2026 with industry partners.
- The report examines gene therapy’s history, technologies, policies, capital markets, supply chains, manufacturing challenges, clinical progress, reimbursement, and competition.
- It identifies challenges and opportunities involving vector technology, large-scale manufacturing, clinical translation, reimbursement, and regulation.
- Frost & Sullivan says the report offers market insights and strategic guidance to support gene therapy’s maturity, standardization, and scalability.
Insights by Ground AI
30 Articles
30 Articles
Coverage Details
Total News Sources30
Leaning Left3Leaning Right3Center20Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
12%
C 77%
11%
Factuality
To view factuality data please Upgrade to Premium
